BRIEF — Bridgebio Oncology Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Oct 12 (Reuters) — BridgeBio Oncology Therapeutics Inc: Bridgebio Oncology Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Source text:... Further company coverage: BBOT.O (Reuters.Briefs@thomsonreuters.com;)
Story updates
10:20:35 PM UTC
SquawkNews
BRIEF – Penguin Solutions Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
10:21:13 PM UTC
SquawkNews
BRIEF – Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)